Search Drug Information, Interactions, Images, Dosage & Side Effects

Relugolix combo therapy could reduce HMB-related anaemia, distress 13 Aug 2020

Relugolix combination therapy (relugolix-CT) comprising relugolix and estradiol (E2)/norethindrone acetate (NETA) could improve anaemia in women with heavy menstrual bleeding (HMB) due to uterine fibroids, according to pooled results of the phase III LIBERTY* 1 and 2 trials presented at ESHRE 2020.

Plasma riboflavin may be a marker for ESCC outcomes

13 Aug 2020

Switching to B/F/TAF combo maintains viral suppression in elderly with HIV

13 Aug 2020

Starting lipid-lowering therapy for ASCVD prevention: How early and in whom?

13 Aug 2020

Charlson Comorbidity Index a valuable tool in estimating renal cell carcinoma prognosis

13 Aug 2020

Statins may protect against C. difficile infections

13 Aug 2020

Exposure to air pollution ups risk of hospitalization for depression

13 Aug 2020

HIV does not worsen COVID-19 outcomes

13 Aug 2020

Personalized TAK-660 prophylaxis may prevent bleeds in severe haemophilia A

13 Aug 2020

Singaporean smokers with psychiatric illnesses unlikely to quit

13 Aug 2020

Do GERD and asthma represent one-two punch for children?

13 Aug 2020

Empagliflozin advancing on all fronts: Readying for the future with EMPEROR 11 Aug 2020;
In this final issue of our series, join us as we look into the upcoming results of the pivotal EMPEROR trials, which will investigate the use of empagliflozin in patients with either preserved or reduced ejection fraction heart failure, with or without type 2 diabetes. Understand why heart failure has such a high clinical burden, and the great unmet need in providing solutions for it.

Product Highlight - FLANAX

24 Jul 2020

Product Highlight - Tationil 600

24 Jul 2020

Product Highlight - FLAGYL

24 Jul 2020

Soliqua

Contents : Per 100 u/mL + 50 mcg/mL soln for inj (10-40 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 50 mcg. Per 100 u/mL + 33 mcg/mL soln for inj (30-60 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 33 mcg

Indications/Uses : In combination w/ metformin for adults w/ type 2 DM to improve glycaemic control when metformin alone, or metformin combined w/ another oral glucose lowering drugs, or w/ basal insulin does not provide adequate glycaemic control.

Tationil 600

Contents : Glutathione

Indications/Uses : Adjunct treatment to minimize the occurrence of toxicity associated w/ cisplatin chemotherapy.

Mycozole/Mycozole IV

Contents : Fluconazole

Indications/Uses : Systemic infections including systemic candidiasis, coccidioidomycosis & cryptococcosis; blastomycosis, histoplasmosis & sporotrichosis; fungal skin infections.

Apidra Solostar

Contents : Insulin glulisine

Indications/Uses : Treatment of adults, adolescents & childn ≥6 yr w/ DM, where treatment w/ insulin is required.

Flanax/Flanax Forte

Contents : Naproxen Na

Indications/Uses : Relief of mild to moderately severe pain & fever w/ or w/o accompanying inflammation eg musculoskeletal trauma, post-op pain & post-dental extraction. Relief of pain associated w/ postpartum cramping & dysmenorrhea. Treatment of acute migraine attack.

Humer 150 Isotonic Nasal Spray

Contents : Sea water

Indications/Uses : For daily hygiene of nasal passages, as supportive treatment of ENT pathologies disorders or moisturize the mucosa.

Flagyl

Contents : Metronidazole

Indications/Uses : Amebiasis; urogenital trichomoniasis; non-specific vaginitis; giardiasis. Curative treatment of medico-surgical infections due to susceptible anaerobic pathogens. Prophylaxis against infections caused by susceptible anaerobic pathogens in high risk surgical contexts. Conversion from prophylactic or curative injectable treatment of infections due to susceptible anaerobic pathogens.

Loxeva

Contents : Levofloxacin

Indications/Uses : Treatment of community-acquired pneumonia, UTI including complicated UTI, skin & soft tissue infections. Tab: Treatment of adults >18 yr w/ mild, moderate & severe infections caused by susceptible strains of microorganisms in the following diseases: Nosocomial pneumonia, acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, chronic bacterial prostatitis; mild to moderate uncomplicated skin & skin structure infections, acute pyelonephritis & uncomplicated UTI.

Renvela

Contents : Sevelamer carbonate

Indications/Uses : Control of serum phosphorus (P) in patients w/ chronic kidney disease (CKD) on dialysis; hyperphosphatemia in adults receiving hemo- or peritoneal dialysis. Adult CKD patients not on dialysis w/ serum P >1.78 mmol/L (5.5 mg/dL). Control of serum P in ped patients (>6 yr & BSA of >0.75 m²) w/ CKD.

New Molecule

4 New

New Formulation

1 New

Velpanat

New Indication

2 New

New Presentation

2 New

pill identifier

Shape

Form

Color 1

Color 2

Markings

Shape

Form

Color 1

Color 2

Search Drug Information, Images & Medical News | MIMS Philippines

Soliqua

Tationil 600

Mycozole/Mycozole IV

Apidra Solostar

Flanax/Flanax Forte

Humer 150 Isotonic Nasal Spray

Flagyl

Loxeva

Renvela

Medolev 125/Medolev 275

Toujeo

Exerta